Description
Product details
PIOSTERIS 15 Pioglitazone (15mg) Introduction: Diabetes mellitus is a prevalent chronic condition that requires effective management to prevent complications and improve quality of life. Among the arsenal of medications available for the treatment of type 2 diabetes mellitus (T2DM), Pioglitazone has emerged as a valuable therapeutic option. PIOSTERIS 15, featuring Pioglitazone at a dosage of 15mg, represents a significant advancement in the management of T2DM. This article explores the features, efficacy, safety profile, and clinical implications of PIOSTERIS 15 in diabetes care. Understanding Pioglitazone: Pioglitazone belongs to the class of thiazolidinediones (TZDs), which act primarily by improving insulin sensitivity in peripheral tissues such as adipose tissue, skeletal muscle, and liver. By activating peroxisome proliferator-activated receptor gamma (PPAR-γ) receptors, Pioglitazone enhances glucose uptake and utilization, leading to improved glycemic control in patients with T2DM. Key Features of PIOSTERIS 15: PIOSTERIS 15 is a pharmaceutical formulation containing Pioglitazone at a standardized dosage of 15mg per tablet. This dosage strength provides clinicians with the flexibility to tailor treatment regimens to individual patient needs, ensuring optimal glycemic control. The formulation of PIOSTERIS 15 ensures consistency and reliability in dosing, facilitating effective diabetes management. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 https://www.sterisonline.com/product/piosteris-15-133429
